Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Envalior is a global leader in high-performance engineering materials, established in 2023 through the merger of DSM Engineering Materials and LANXESS High Performance Materials. The company specializes in developing and manufacturing advanced polymers and specialty plastics used in demanding environments across the automotive, electronics, and healthcare sectors. In the healthcare industry, Envalior provides medical-grade materials for surgical instruments, diagnostic equipment, and drug delivery devices, focusing on biocompatibility, sterilization resistance, and mechanical durability. Headquartered in Düsseldorf, Germany, the company operates as a joint venture between private equity firm Advent International and specialty chemicals company LANXESS.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Envalior.